Mild Cognitive Impairment Clinical Trials in New York, New York

8 studies are recruiting for mild cognitive impairment in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

   The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Icahn School of Medicine at Mount Sinai, New York, New York

   Locations

   31 in total

   Run by

   Massachusetts General Hospital

   See if you can join NCT04916210 on ClinicalTrials.gov

2. Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity

   The purpose of this study is to see if 6 months of home-based walking will improve memory, and brain structure and function, compared to health education in older adults that have chronic kidney disease and mild cognitive impairment.

   Stage

   Not phased

   Ages

   55 and older

   Site

   Columbia University, New York, New York

   Locations

   2 in total

   Run by

   Columbia University

   See if you can join NCT05655325 on ClinicalTrials.gov

3. Olfactory Training in Mild Cognitive Impairment

   Sense of smell tends to decline in individuals with early Alzheimer's disease, typically earlier than when other senses and thinking abilities begin to decline. Memory for new odors is particularly diminished in these individuals. Existing treatments for AD do not improve these symptoms. A targeted…

   Stage

   Not phased

   Ages

   55 to 89

   Site

   New York State Psychiatric Institute, New York, New York

   Run by

   Jeffrey Motter

   See if you can join NCT06825403 on ClinicalTrials.gov

4. Autoimmune Features of Neurodegenerative Disorders

   This study is being conducted to better understand the role of inflammation in Parkinson's disease (PD) and Alzheimer's disease (AD). The investigators plan to recruit 30 PD, 30 AD/Amnestic Mild Cognitive Impairment (aMCI), and 60 age matched healthy controls in this study to study the role of immu…

   Stage

   Not phased

   Ages

   55 to 90

   Site

   Columbia University Medical Center, New York, New York

   Run by

   Columbia University

   See if you can join NCT04239079 on ClinicalTrials.gov

5. Digital Tools to Support Healthcare Decision Making

   The goal for this project is to support the cognitive components of older adults' health-management activities through development of digital assistant technology tools tailored to three exemplar healthcare management task activities: accessing support services, managing healthcare finances, and us…

   Stage

   Not phased

   Ages

   60 and older

   Site

   Weill Cornell Medicine, New York, New York

   Locations

   3 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT07485725 on ClinicalTrials.gov

6. Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients

   Participants will randomly be placed into one of four groups and experience one of the four following conditions: (1) a placebo light that provides a 40 hertz (Hz) flicker (rhythmic light [RL]); (2) a placebo light with a random flicker (placebo condition for rhythmic light); (3) a light source tha…

   Stage

   Not phased

   Ages

   55 and older

   Site

   Icahn School of Medicine at Mount Sinai, New York, New York

   Locations

   2 in total

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT05016219 on ClinicalTrials.gov

7. Tau PET in Imaging and Cognition: Healthy Adults From 55-90

   The investigators aim to use the new PET radioligand, 18F-MK-6240, to detect tau pathology in cognitive healthy and mild cognitive impairment (MCI) elders. The investigators will then examine the interactions between differential tau burden and performance on cognitive tasks, functional magnetic re…

   Stage

   Not phased

   Ages

   55 to 90

   Site

   Columbia University Medical Center, New York, New York

   Run by

   Yaakov Stern

   See if you can join NCT03372317 on ClinicalTrials.gov

8. Innate Immunity Stimulation Via TLR9 in Early AD

   This single-center, double-blind, placebo-controlled study will recruit in total 39 participants with either Mild Cognitive Impairment due to Alzheimer's disease (MCI) or Mild Alzheimer's disease dementia (mild AD). There will be 3 Dose levels. An initial cohort of 13 subjects will be randomized to…

   Stage

   Phase 1

   Ages

   60 to 85

   Site

   NYU Langone Health, New York, New York

   Run by

   NYU Langone Health

   See if you can join NCT05606341 on ClinicalTrials.gov